Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Laguna, M Pilar
Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. [electronic resource] - The Journal of urology 03 2017 - 603 p. digital
Publication Type: Journal Article; Comment
1527-3792
10.1016/j.juro.2016.12.059 doi
Carcinoma, Renal Cell
Humans
Indazoles
Kidney Neoplasms
Pyrimidines
Sulfonamides
Sunitinib
Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. [electronic resource] - The Journal of urology 03 2017 - 603 p. digital
Publication Type: Journal Article; Comment
1527-3792
10.1016/j.juro.2016.12.059 doi
Carcinoma, Renal Cell
Humans
Indazoles
Kidney Neoplasms
Pyrimidines
Sulfonamides
Sunitinib